Streetbeat News

Stock Prices

LFLY

Leafly Holdings (NASDAQ:LFLY) reported Q4 earnings with losses of $(0.22) per share, significantly beating the $(1.45) estimate. Sales reached $9.74M, also surpassing the $9.49M estimate but marking a 19.54% decrease from the previous year.

Portfolio Pulse from dijoy@benzinga.com

March 28, 2024 | 8:24 pm

FLOKIUSD

Floki (FLOKI) experienced a 15% price rally following its Valhalla Bonfire Event, where 190.9 billion FLOKI tokens were burned. This event contributed to a significant increase in Floki's market cap, which surged by $2 billion in a month, reaching $2.52 billion. Floki's trading volume closely follows other major meme coins, with a 433.8% monthly gain, outperforming Dogecoin, Shiba Inu, and others. The token's success is attributed to its strong utility demand, deflationary tokenomics, and a 23% supply staked/locked. Binance highlighted Floki as one of the hottest meme coins on its exchange.

Portfolio Pulse from Khyathi Dalal

March 28, 2024 | 8:23 pm

CEAD

CEA Industries (NASDAQ:CEAD) reported a Q4 EPS of $(0.12), improving from $(0.18) YoY. However, sales significantly decreased to $251.00K from $1.46M YoY, marking an 82.82% drop.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:23 pm

OXM

Oxford Industries (NYSE:OXM) reported Q4 2023 earnings of $1.90 per share, missing the $1.95 estimate, and sales of $404.40M, below the $408.18M estimate. This represents a 16.67% decrease in earnings and a 5.73% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:23 pm

ACNT

Ascent Industries reported a Q4 2023 GAAP EPS of $(0.73) and sales of $41.216M, missing the analyst consensus estimate of $63.500M by 35.09%. This represents a 23.93% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:22 pm

SMTC

Semtech has provided its Q1'FY25 financial guidance, expecting net sales of $200M, +/- $5.0M, closely aligning with the estimated $200.57M. The company also forecasts an adjusted EPS of $0.00, +/- $0.04, which is slightly below the estimated $0.02.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:20 pm

INMB

INmune Bio (NASDAQ:INMB) reported Q4 earnings with an EPS of $-0.47, missing estimates by -7%, and a revenue decrease of $69 thousand from the previous year. The company's past earnings miss was followed by a 4% share price drop.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 8:20 pm

RNAC

Cartesian Therapeutics, Inc. (NASDAQ:RNAC), a biotech company, announced the approval of the conversion of its Series A Convertible Preferred Stock and a 1-for-30 reverse stock split effective after trading hours on April 4, 2024. The conversion will occur on April 8, 2024, and the reverse stock split will see the company's common stock trade on a split-adjusted basis starting April 5, 2024. This will reduce the number of outstanding shares from approximately 165.5 million to about 5.5 million before the conversion, and approximately 23.3 million shares after all conversions.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:16 pm

OTLK

Tang Capital Partners has disclosed a 9.99% passive stake in Outlook Therapeutics, indicating a significant investment in the company.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:16 pm

ED

Consolidated Edison's (NYSE:ED) short interest has increased by 7.06% since the last report, with 6.99 million shares sold short, representing 2.73% of its float. This indicates a bearish market sentiment, although it's below the peer group average of 3.27%. The article suggests that an increase in short interest doesn't necessarily predict a stock price fall.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 8:15 pm